The world's scientific and social network for malaria professionals
8803 malaria professionals are enjoying the free benefits of MalariaWorld today

Ingeborg van Schayk's blog

Last week at MalariaWorld: Malaria conference and ALMA Awards

February 5, 2016 - 10:50 -- Ingeborg van Schayk
Conference: Malaria - from innovation to eradication
MESA announces a Save the Date for a joint Keystone-MESA symposium from 19-23 February 2017 in Kampala, Uganda. This conference is about scientific progress towards global malaria elimination and eradication. Read more about this malaria conference here.
 
African Leaders Malaria Alliance (ALMA) Awards for Excellence
African Heads of State gathered on 30 January 2016 to celebrate the progress against malaria elimination in Africa. At this meeting, ALMA presented its annual Awards for Excellence to the following 13 African countries that have shown commitment, innovation and progress in the fight against malaria:
  • Botswana, Cape Verde, Eritrea, Namibia, Rwanda, São Tomé and Príncipe, South Africa, and Swaziland for achieving the Millennium Development Goals (MDGs) target for malaria
  • Rwanda, Senegal and Liberia for Performance in Malaria Control between 2011 and 2015
  • Mali, Guinea and Comoros for being the Most Improved in Malaria Control between 2011 and 2015
MalariaWorld congratulates these countries with these achievements!
 
Blog: The prophylactic effect of artemisia
In his artemisia series Pierre Lutgen describes why the consumption of Artemisia infusion or capsules can work as a prophylaxis against malaria. Read "The strong prophylactic and antimalarial properties of polyunsaturated fatty acids" here.
 
Enjoy this week's MalariaWorld - the MW team
and we look forward to receiving your manuscripts for the MalariaWorld Journal!
 

Share your announcement on MalariaWorld
Do you have a vacancy, event, or other announcement that you want to share with the global malaria community. Use MalariaWorld to reach 8700+ malaria professionals in 140 countries. Read about advertising on MalariaWorld here or send an email to info@malariaworld.org.
 

Support MalariaWorld to provide Open Access to malaria information for all.  We will use your donation solely to further develop MalariaWorld. MalariaWorld is a project of the Dutch Malaria Foundation, a charitable, registered, not-for-profit organisation. If you still have any questions then just contact us at donate@malariaworld.org

 

MalariaWorld Journal (MWJ) is the only peer-reviewed Open Access journal on malaria where you don’t pay to publish, you don’t pay to read, and authors get paid € 150 for each published paper. Read about MW and how you can submit your manuscript here.

 


Log in at MalariaWorld. Remember that you have to log-in at MW to read more, respond to polls, open attachments and get free copies of books and other documents. Forgot your username and/or password? Go to www.malariaworld.org, click on Sign in and then on Request new password. Fill out your email address that you use to receive the MW newsletter and the Word verification. You will then receive further instructions by email.

 

Press release: Researchers receive $10.2 million to study new malaria-prevention method

December 11, 2015 - 06:43 -- Ingeborg van Schayk
UNIVERSITY PARK, Pa. -- In collaboration with partners in Europe and Africa, researchers at Penn State have received a five-year, $10.2-million grant from the Bill & Melinda Gates Foundation to investigate a new method for preventing the transmission of malaria. The method involves limiting mosquito access to houses by blocking openings and installing "eave tubes" that contain a unique type of insecticide-laced mosquito netting developed by Dutch partner In2Care that kills the insects as they attempt to enter. 
 

Testing for malaria reduces overprescription by over 70%

July 24, 2015 - 08:19 -- Ingeborg van Schayk

Introducing rapid diagnostic tests in Ugandan drug shops improves treatment of malaria patients

Using malaria rapid diagnostic tests (RDT) in registered drug shops in a highly endemic region in Uganda substantially reduced overdiagnosis of malaria, improving the use of valuable malaria drugs, according to a new study published in PLOS ONE.

The International PfSPZ Consortium meets to review data and map out the clinical development pathway for the Plasmodium falciparum sporozoite-based vaccines

July 2, 2015 - 17:38 -- Ingeborg van Schayk

Candidate vaccines based on injectable Plasmodium falciparum (Pf) sporozoites (SPZ), are being developed and tested. These include PfSPZ Vaccine, in which the PfSPZ are attenuated by irradiation; PfSPZ-CVac, in which fully infectious PfSPZ, PfSPZ Challenge, are attenuated in vivo by an anti-malarial drug, to allow only liver stage parasites to grow, and PfSPZ-GA1, in which the PfSPZ are attenuated by gene deletions.

Pages

Subscribe to RSS - Ingeborg van Schayk's blog